Colony Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Colony Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$742K	Buy	10,168 +11	+0.1%	+$879	0.01%	483
2023 Q2	$845K	Buy	10,157 +3,221	+46%	+$269K	0.01%	464
2023 Q1	$529K	Sell	6,936 -3,750	-35%	-$311K	0.01%	557
2022 Q4	$887K	Buy	10,686 +189	+2%	+$15.3K	0.01%	508
2022 Q3	$833K	Buy	10,497 +1,612	+18%	+$136K	0.01%	475
2022 Q2	$660K	Sell	8,885 -32,520	-79%	-$2.44M	0.01%	541
2022 Q1	$3.72M	Buy	41,405 +36,932	+826%	+$3.41M	0.06%	269
2021 Q4	$501K	Hold	4,473	–	–	0.01%	595
2021 Q3	$562K	Hold	4,473	–	–	0.01%	548
2021 Q2	$606K	Sell	4,473 -205	-4%	-$27K	0.01%	485
2021 Q1	$635K	Hold	4,678	–	–	0.01%	486
2020 Q4	$659K	Sell	4,678 -504	-10%	-$64.6K	0.02%	441
2020 Q3	$577K	Buy	5,182 +48	+0.9%	+$5.38K	0.02%	456
2020 Q2	$575K	Sell	5,134 -312	-6%	-$30.7K	0.02%	434
2020 Q1	$422K	Buy	5,446 +443	+9%	+$39.2K	0.01%	488
2019 Q4	$476K	Buy	5,003 +205	+4%	+$17.7K	0.01%	541
2019 Q3	$366K	Buy	+4,798	New	+$399K	0.01%	543
2019 Q2	–	Sell	-2,276	Closed	-$206K	–	743
2019 Q1	$206K	Buy	+2,276	New	+$194K	0.01%	601
2018 Q4	–	Sell	-2,276	Closed	-$218K	–	544
2018 Q3	$218K	Buy	2,276 +2	+0.1%	+$194	0.01%	474
2018 Q2	$216K	Sell	2,274 -132	-5%	-$12.1K	0.01%	465
2018 Q1	$211K	Buy	2,406 +2	+0.1%	+$183	0.01%	468
2017 Q4	$204K	Buy	+2,404	New	+$201K	0.01%	464
2016 Q1	–	Sell	-1	Closed	–	–	665
2015 Q4	$0	Buy	+1	New	+$68	﹤0.01%	913
2015 Q1	–	Sell	-936	Closed	-$58K	–	803
2014 Q4	$58K	Buy	+936	New	+$53.4K	0.01%	431

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Colony Group's XBI Position: Q3 2023 in Review

Colony Group increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.11% in Q3 2023, buying an estimated $879 and bringing the position to 10,168 shares worth $742K. The position accounts for 0.01% of the portfolio, ranked #483.

Colony Group first reported a position in XBI in Q4 2014 and has held it in 24 quarters since. The position peaked at $3.72M in Q1 2022. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

Colony Group held 10,168 shares of State Street SPDR S&P Biotech ETF worth $742K as of Q3 2023.
Colony Group bought 11 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $879.
State Street SPDR S&P Biotech ETF made up 0.01% of Colony Group's portfolio in Q3 2023, its #483 holding.
Colony Group first reported a position in State Street SPDR S&P Biotech ETF in Q4 2014 and has held it in 24 quarters since.
Colony Group's State Street SPDR S&P Biotech ETF position peaked at $3.72M in Q1 2022.
679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.